| Name | Section 226: Proteoglycan and Basement Membrane Therapy in CBS/PSP |
| Summary | Proteoglycan biology, basement membrane dysfunction in tauopathy, HSPG modulation strategies, perineuronal net targeting, and therapeutic approaches for CBS/PSP: heparan sulfate, chondroitin sulfate, keratan sulfate, ECM remodeling |